l-carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Gut Microbiota-Dependent Marker TMAO in
Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target PMC TMAO metaorganismal pathway and chronic inflammatory diseases Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review Gut Microbiota Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Trimethylamine N Oxide (TMAO) as a Rising Star Metabolite: Implications for Human Health Trimethylamine N Oxide in Relation to Cardiometabolic HealthCause or Effect?
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 20 - Sep 25





